Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(22 sites)
United States
Kailera Clinical Site, Anniston, Alabama Kailera Clinical Site, Cullman, Alabama Kailera Clinical Site, Sun City, Arizona Kailera Clinical Site, Escondido, California Kailera Clinical Site, Toluca Lake, California Kailera Clinical Site, Aurora, Colorado Kailera Clinical Site, Bridgeport, Connecticut Kailera Clinical Site, Jupiter, Florida Kailera Clinical Site, Lilburn, Georgia Kailera Clinical Site, Springfield, Illinois Kailera Clinical Site, Columbia, Maryland Kailera Clinical Site, Las Vegas, Nevada Kailera Clinical Site, Rochester, New York Kailera Clinical Site, Morehead City, North Carolina Kailera Clinical Site, Chickasha, Oklahoma Kailera Clinical Site, Mauldin, South Carolina Kailera Clinical Site, Chattanooga, Tennessee Kailera Clinical Site, Amarillo, Texas Kailera Clinical Site, DeSoto, Texas Kailera Clinical Site, Tomball, Texas Kailera Clinical Site, Salt Lake City, Utah Kailera Clinical Site, Danville, Virginia